The FDA Posted Briefing Documents For Grails Galleri Test Review Ahead Of The Molecular And Clinical Genetics Panel Of The Medical Devices Advisory Committee That Is Being Held On September 23; Flags No Major Concerns For Co's Cancer Test

The FDA has released briefing documents for the review of Grail's Galleri test ahead of the Medical Devices Advisory Committee meeting scheduled for September 23. The documents indicate no major concerns regarding the company's cancer test. This review could impact Grail's market position and regulatory approval process.